908 Devices Inc. reported a 4% decrease in revenue to $14.0 million for Q3 2025 compared to the prior year, primarily due to fewer mass spec device placements. Despite this, the company achieved its best Adjusted EBITDA performance in its public company history, with a loss of $1.8 million, and saw its installed base grow 27% year-over-year to 3,512 devices.
Revenue for Q3 2025 was $14.0 million, a 4% decrease over the prior year period.
The installed base grew 27% year-over-year to 3,512 devices, with 176 devices placed during the quarter.
Adjusted EBITDA loss improved by 53% quarter over quarter, reaching a loss of $1.8 million.
Cash, cash equivalents and marketable securities stood at $112.1 million as of September 30, 2025, with no debt.
908 Devices continues to expect full year 2025 revenues from continuing operations to be in the range of $54.0 million to $56.0 million, representing 13% to 17% growth compared to 2024.
Visualization of income flow from segment revenue to net income